Macrogen, Inc. (KOSDAQ:038290)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,140
-270 (-1.75%)
Oct 30, 2025, 3:30 PM KST
-1.75%
Market Cap167.07B
Revenue (ttm)163.92B
Net Income (ttm)-6.47B
Shares Out10.84M
EPS (ttm)-620.90
PE Ration/a
Forward PE32.72
Dividend300.00 (1.95%)
Ex-Dividend DateDec 27, 2024
Volume30,929
Average Volume23,113
Open15,370
Previous Close15,410
Day's Range15,110 - 15,530
52-Week Range14,700 - 19,150
Beta0.69
RSI42.89
Earnings DateAug 14, 2025

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 500
Stock Exchange KOSDAQ
Ticker Symbol 038290
Full Company Profile

Financial Performance

In 2024, Macrogen's revenue was 135.78 billion, an increase of 2.24% compared to the previous year's 132.80 billion. Losses were -7.60 billion, -54.78% less than in 2023.

Financial Statements

News

There is no news available yet.